Andrew C. Charles, MD

home / authors / andrew-c-charles-md

Articles

Future Directions for the Management of Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

June 1st 2022

Bradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.

Emerging Therapies for Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

June 1st 2022

Experts in headache medicine review novel therapeutic agents under investigation and the evolving treatment landscape for migraine.

Assessing Treatment Response and Efficacy for Migraine Therapy

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 25th 2022

Julio R. Vieira, MD, leads a discussion on the importance of follow-up visits for patients with migraine and considerations for switching therapies.

CGRP Monoclonal Antibodies for Preventive Treatment of Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 25th 2022

Andrew C. Charles, MD; Bradley Torphy, MD; and Jessica Ailani, MD, review current FDA approved CGRP monoclonal antibodies available for the preventive treatment of migraine.

Using CGRP Antagonists for the Treatment of Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 18th 2022

Experts in headache medicine discuss the role of CGRP-based therapy for migraine prevention.

AHS and NHF Consensus Statements for Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 18th 2022

Drs Bradley Torphy and Jessica Ailani share thoughts on using consensus statements to guide the treatment of migraine.

Acute and Preventive Treatment Options for Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 10th 2022

Sait Ashina, MD, reviews current AHS (American Headache Society) treatment recommendations for the acute and preventive treatment of migraine.

Acute Versus Preventative Treatment of Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 10th 2022

Dr Julio R. Vieira defines acute versus preventive treatment for migraine and highlights the differences in goals of therapy for each.

Approaching the Treatment of Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 3rd 2022

Sait Ashina, MD, and Jessica Ailani, MD, comment on the importance of individualized treatment regimens for the management of migraine.

Using Diagnostic Tools to Assess Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

May 3rd 2022

Experts in neurology, Drs Julio R. Vieira, Jessica Ailani, and Bradley Torphy review diagnostic tools available for migraine, including patient use of headache diaries.

Differentiating Migraine From Other Headache Disorders

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

April 26th 2022

Jessica Ailani, MD, and Bradley Torphy, MD, discern the signs of migraine and comment on the importance of ensuring accurate diagnosis for patients.

Challenges of Migraine Diagnosis

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

April 26th 2022

Drs Bradley Torphy and Julio R. Vieira share insight on approaching the diagnosis of migraine as well as current challenges in diagnosis.

Reducing Clinical Burden of Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

April 19th 2022

Andrew C. Charles, MD; Jessica Ailani, MD; and Sait Ashina, MD, discuss the impact of migraine on a patient’s quality of life and share strategies for reducing the clinical burden of disease.

Pathophysiology of Migraine

Jessica Ailani, MD;Bradley Torphy, MD;Sait Ashina, MD;Andrew C. Charles, MD;Julio R. Vieira, MD

April 19th 2022

Andrew C. Charles, MD, and Sait Ashina, MD, provide an overview of the pathophysiology of migraine and discuss its 5 clinical phases.

The Changing Landscape of Preventative Migraine Treatments

Jessica Ailani, MD;Stephanie J. Nahas, MD, MSEd;Rebecca Erwin Wells, MD, MPH;Andrew C. Charles, MD;Christopher Gottschalk, MD

January 14th 2022

A panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.

Headache Specialists for Preventative Migraine Treatments

Jessica Ailani, MD;Stephanie J. Nahas, MD, MSEd;Rebecca Erwin Wells, MD, MPH;Christopher Gottschalk, MD;Andrew C. Charles, MD

January 7th 2022

A discussion on when a patient should be referred to a headache specialist for preventive migraine treatment.

Preventative Migraine Therapies: The ADVANCE Trial and the Future

Jessica Ailani, MD;Rebecca Erwin Wells, MD, MPH;Christopher Gottschalk, MD;Stephanie J. Nahas, MD, MSEd;Andrew C. Charles, MD

January 7th 2022

Jessica Ailani, MD, details how the phase 3 ADVANCE trial will shape the research of future agents for preventive migraine treatment.

Oral Agents for Preventative Migraine Treatment

Jessica Ailani, MD;Andrew C. Charles, MD;Stephanie J. Nahas, MD, MSEd;Christopher Gottschalk, MD;Rebecca Erwin Wells, MD, MPH

December 31st 2021

A key opinion leader discusses the use of oral agents for the preventive treatment of migraine.

CGRP Monoclonal Antibodies and Patient Treatment Selection

Jessica Ailani, MD;Stephanie J. Nahas, MD, MSEd;Rebecca Erwin Wells, MD, MPH;Andrew C. Charles, MD;Christopher Gottschalk, MD

December 31st 2021

Dr Christopher Gottschalk shares how the clinical trial data for CGRP monoclonal antibodies affect patient selection for preventive migraine treatment.